Literature DB >> 4999907

Pyelonephritis. XII. Comparison of penicillin, ampicillin, and streptomycin in enterococcal infection in rats.

F L Sapico, G M Kalmanson, J Z Montgomerie, W L Hewitt, L B Guze.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4999907     DOI： 10.1093/infdis/123.6.611

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  6 in total

1.  Activity of LY146032 in vitro and in experimental enterococcal pyelonephritis.

Authors:  P M Miniter; T F Patterson; M A Johnson; V T Andriole
Journal:  Antimicrob Agents Chemother       Date:  1987-08       Impact factor: 5.191

2.  Treatment of enterococcal pyelonephritis with trovafloxacin and rifampin: in vitro-in vivo contrast.

Authors:  J Z Montgomerie; D G Schick
Journal:  Antimicrob Agents Chemother       Date:  1998-01       Impact factor: 5.191

3.  Mode of action of lividomycin on protein synthesis in Escherichia coli.

Authors:  M Yamaguchi; J Eda; F Kobayashi; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1973-09       Impact factor: 5.191

4.  LY146032, alone and in combination with gentamicin, for the treatment of enterococcal pyelonephritis in the rat model.

Authors:  F L Sapico; V J Ginunas; H N Canawati; J Z Montgomerie
Journal:  Antimicrob Agents Chemother       Date:  1988-01       Impact factor: 5.191

5.  Rifampin, ampicillin, streptomycin, and their combinations in the treatment of enterococcal pyelonephritis in rats.

Authors:  P A Oill; G M Kalmanson; L B Guze
Journal:  Antimicrob Agents Chemother       Date:  1981-10       Impact factor: 5.191

6.  In vitro activity of ampicillin or vancomycin combined with gentamicin or streptomycin against enterococci.

Authors:  H J Harwick; G M Kalmanson; L B Guze
Journal:  Antimicrob Agents Chemother       Date:  1973-10       Impact factor: 5.191
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.